Immix Biopharma | 10-K: Annual report
Mar 30 04:09
Immix Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 21 01:46
Immix Biopharma | 424B5: Prospectus
Feb 8 06:17
Immix Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(5.8%),Orin H(5.8%)
Feb 7 22:21
Immix Biopharma | 8-K: Current report
Feb 6 22:12
Immix Biopharma | 424B5: Prospectus
Feb 6 05:46
Immix Biopharma | 8-K: Current report
Feb 6 05:38
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Dec 13, 2023 07:25
Immix Biopharma: Q3 2023 Earnings Report
Nov 10, 2023 09:24
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CFO Morris Gabriel S
Nov 10, 2023 08:57
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Rachman Ilya M
Nov 10, 2023 08:54
Immix Biopharma | EFFECT: Others
Sep 29, 2023 12:15
Immix Biopharma | CORRESP: CORRESP
Sep 27, 2023 04:30
Immix Biopharma | UPLOAD: Others
Sep 27, 2023 03:30
Immix Biopharma | S-3: Registration statement for specified transactions by certain issuers
Sep 26, 2023 04:15
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Sep 19, 2023 07:03
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey
Sep 16, 2023 06:27
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adams Helen C.
Sep 15, 2023 05:20
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Sep 13, 2023 04:58
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHAN MELISSA JANE
Sep 12, 2023 05:18
No Data
No Data